Clinical Trial Update: Perioperative Therapy for HER2-negative Hepatoid Adenocarcinoma of Stomach [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating perioperative therapy for patients with HER2-negative hepatatoid adenocarcinoma of the stomach; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatoid Adenocarcinoma of Stomach

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Hepatoid Adenocarcinoma of Stomach | Phase 2 | Status: RECRUITING